Frontier IP's portfolio company TVG advances ASF vaccine candidate
The vaccine developer has reached a key milestone in the development of its African Swine Fever vaccine candidate.
The vaccine developer has reached a key milestone in the development of its African Swine Fever vaccine candidate.
The animal health company has signed an option to license agreement with Frontier IP's portfolio company to develop a vaccine against a pig disease.
The financial services company has disclosed a director's share sale and repurchase transaction.
The asset management company has disclosed that two directors have sold and repurchased shares, with their total holdings unchanged.
The intellectual property commercialization specialist reported a pre-tax loss and challenging market conditions. Despite portfolio progress, potential exits may face delays due to the current economic climate, with limited visibility on organic growth and margins.
The technology company has secured €25 million in Series A funding to accelerate the development and scale-up of its advanced graphene photonics transceivers, which have the potential to transform artificial intelligence and mobile communications.
The technology company has been recognized for its innovative power electronics design that delivers industry-leading energy efficiency.
The asset management firm's portfolio company has entered a collaboration to develop advanced solar technology, securing a significant grant from Innovate UK.
The specialist IP commercialization firm announces the launch of its portfolio company Alusid's sustainable Mas floor tile range through major UK retailer Topps Tiles.
Sustainable materials firm Frontier IP's portfolio company Alusid signs first international distribution deal, expanding its global reach.